Session Information

  • WCLC 2020

    2020 World Conference on Lung Cancer

    Conference Program for the 2020 World Conference on Lung Cancer in Singapore


    Presentation Date(s):  
    • January 28 - 31, 2021
    • Total Presentations: 1597

    All times listed are in Singapore time (GMT+8)

    PL - Plenary
    PS - Presidential Symposium
    ES - Education Session
    OA - Oral Session
    MA - Mini Oral Session
    FP - Featured Posters
    P - Posters
    IS - Industry Symposium
    JICC - Joint IASLC-CAALC-CSCO Session

Filter Results:

Show Only CME Accredited Sessions

  • +

    FP14 - Targeted Therapy - Clinically Focused

    • 00:00 - 00:00
    • 1/28/2021
    • Location: ePoster Hall
    • Type: Posters (Featured)
    • Track: Targeted Therapy - Clinically Focused
    • +

      FP14.13 - Molecular Characterisation and Clinical Outcomes in RET Rearranged Non-Small Cell Lung Cancer (NSCLC)

      00:00 - 00:00  |  Presenter: Aaron C Tan

      • Abstract

      Loading...

  • +

    P38 - Pathology - Pathology/Staging

    • 00:00 - 00:00
    • 1/28/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Pathology, Molecular Pathology and Diagnostic Biomarkers
    • +

      P38.03 - Immunohistochemical, Histologic and Genomic Characterisation of Early Stage Pulmonary Invasive Mucinous Adenocarcinoma

      00:00 - 00:00  |  Presenter: Aaron C Tan

      • Abstract

      Loading...

  • +

    P59 - Tumor Biology and Systems Biology - Basic and Translational Science - Genomics

    • 00:00 - 00:00
    • 1/28/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Tumor Biology and Systems Biology - Basic and Translational Science
    • +

      P59.08 - THOR: Multi-Ethnic, Open Access Thoracic Cancer Genomics Resource

      00:00 - 00:00  |  Presenter: Anders Skanderup

      • Abstract

      Loading...

  • +

    P76 - Targeted Therapy - Clinically Focused - EGFR

    • 00:00 - 00:00
    • 1/28/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Targeted Therapy - Clinically Focused
    • +

      P76.46 - First-Line Osimertinib in Asian Patients with Advanced EGFR-Mutant Lung Cancer  

      00:00 - 00:00  |  Presenter: Wan-Ling Tan

      • Abstract

      Loading...

  • +

    OA01 - Established Drugs in Special Populations and New Drugs in Established Populations

    • 09:15 - 10:15
    • 1/29/2021
    • Location: Scientific Program Auditorium
    • IASLC CME Accredited
    • Type: Oral
    • Track: Immunotherapy (Phase II/III Trials)
    • +

      OA01.06 - Randomised Phase 2 Study of Nivolumab (N) Versus Nivolumab and Ipilimumab (NI) Combination in EGFR Mutant NSCLC

      09:40 - 09:50  |  Presenter: Gillianne Geet Yi Lai

      • Abstract

      Loading...

  • +

    OA04 - New Data from Rare EGFR Alterations

    • 11:45 - 12:45
    • 1/29/2021
    • Location: Scientific Program Auditorium
    • IASLC CME Accredited
    • Type: Oral
    • Track: Targeted Therapy - Clinically Focused
    • +

      OA04.07 - Discussant

      12:25 - 12:35  |  Presenter: Gillianne Geet Yi Lai

      • Abstract

      No abstract available for this presentation

  • +

    OA06 - Updates on EGFR Targeted Perioperative Therapy and Precision Adjuvant Chemotherapy

    • 16:45 - 17:45
    • 1/29/2021
    • Location: Scientific Program Auditorium
    • IASLC CME Accredited
    • Type: Oral
    • Track: Early Stage/Localized Disease
    • +

      OA06.05 - Molecular and Clinical Features Associated with Relapse in Early Stage EGFR-Mutated NSCLC: A Single Institution Knowledge Bank

      17:05 - 17:15  |  Presenter: Stephanie Pei Li Saw

      • Abstract

      Loading...

  • +

    MA13 - Tumor Biology: Focus on EGFR Mutation, DNA Repair and Tumor Microenvironment

    • 16:45 - 17:45
    • 1/31/2021
    • Location: Scientific Program Auditorium
    • IASLC CME Accredited
    • Type: Mini Oral
    • Track: Tumor Biology and Systems Biology - Basic and Translational Science
    • +

      MA13.08 - Genomic and Transcriptomic Features of Distinct Resistance Trajectories in EGFR Mutant Non-Small Cell Lung Cancer (NSCLC)

      17:25 - 17:30  |  Presenter: Aaron C Tan

      • Abstract

      Loading...